GWHP Corp Sources Wholesale PPE Supplies and COVID-19 Diagnostic Testing Kits During The Pandemic

Global WholeHealth Partners is committed to sourcing and supplying in demand COVID-19 diagnostic testing kits and PPE supplies even as COVID-19 cases begin to decline as a result of the distribution and administering of the Pfizer and Moderna vaccines.

We have become the trusted choice for PPE supplies and COVID-19 diagnostic testing kits thanks to our longstanding relationship with key players in the industry. It is this reason that we are able to continually source high quality PPE supplies and COVID-19 diagnostic testing kits in wholesale quantities.

COVID-19 still affects the world at large even with the vaccines currently being distributed and administered and with social distancing measures in place. We all can do our part to help slow the spread of COVID-19 by social distancing where we can, staying quarantined when we are sick, and using PPE supplies when leaving the house. Masks wearing is still required or recommended in most public indoor places such as shopping malls, grocery stores and restaurants and often times negative COVID-19 tests are required for travel.

Get in touch with GWHP Corp today for more information. Visit our medical supply page to view our current inventory and get in touch with our specialists to place your wholesale PPE supplies order or wholesale COVID-19 diagnostic testing kits order. We can be reached at 877-568-4947.


About Global WholeHealth Partners OTC (GWHP)
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 - 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.